Seeking Alpha A variety of factors have made things difficult for the drug conglomerate. It is important to outline what created a weak quarter for the company and t...
GlobeNewswire (press release) "Strong demand for Protein A ligands and our growth factor products as well as increased interest in our OPUS® chromatography columns contributed to the revenue gains during our first quarter. We view all of our bioprocessing products as well ... and more »
Sun-Sentinel Approximately two-thirds of anemic patients were managed with drug dose reductions, which minimized the need for expensive growth factors and blood transfusions. The analysis also reveals that patients with cirrhosis were at increased risk for ...
Reuters UK SANOFI The pharmaceutical maker reported lower-than-expected first-quarter earnings on Thursday as the effects of last year's patent losses damped growth from diabetes drugs , vaccines and rare disease unit Genzyme. CAPGEMINI The information ... and more »
Reuters The drugs , known as leukocyte growth factors , will be the subject of a Friday meeting of an advisory committee to the U.S. Food and Drug Administration. Treatment with Amgen's Neupogen and Neulasta, Teva's Tbo-filgrastim and Sanofi's Leukine, may ...
Gizmodo Australia The drugs in question, known as leukocyte growth factors , are currently used primarily by cancer patients for their white-blood-cell-boosting prope...
Bloomberg Medications known as leukocyte growth factors , which also include Sanofi (SAN)'s Leukine, may help decrease death rates from radiation exposure, Food and Dr...
